Pharmagen ApS: Financial statements 2022
CVR: 36687193
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
Pharmagen ApS (CVR 36687193) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 7,857 and a net result of DKK -242,071 compared with DKK 383,322 the year before. That is a decrease of 97.7% compared with the year before. Equity in the 2022 report amounted to DKK -307,167.
- Gross Profit
- DKK 7,857
- Profit/Loss
- DKK -242,071
- Equity
- DKK -307,167
- Total Assets
- DKK 965,821
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 8 t. | -242 t. | -307 t. | - |
| 2021 | - | 337 t. | 383 t. | -65 t. | - |
| 2020 | - | 373 t. | 76 t. | -448 t. | - |
| 2019 | - | 382 t. | -907 t. | -524 t. | - |
| 2018 | - | 345 t. | -237 t. | 383 t. | - |
Official annual report
Keep an eye on Pharmagen ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Pharmagen ApS
Pharmagen ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mads Juul Hedegaard. The company is owned by Hans-Ole Hedegaard. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -15,933 and a net result of DKK 36,023 compared with DKK -19,304 the year before. Equity in the 2025 report amounted to DKK -275,141.